Literature DB >> 30206181

Postprandial bile acid levels in intestine and plasma reveal altered biliary circulation in chronic pancreatitis patients.

Lydie Humbert1, Dominique Rainteau2,3, Noshine Tuvignon4,5, Claude Wolf6, Philippe Seksik1,7, René Laugier4,5, Frédéric Carrière8.   

Abstract

Bile acid (BA) secretion and circulation in chronic pancreatitis (CP) patients with exocrine pancreatic insufficiency (EPI) were investigated by simultaneously measuring postprandial levels of individual BAs in duodenal contents and blood plasma using LC-MS/MS. CP patients and healthy volunteers (HVs) were intubated with gastric and duodenal tubes prior to the administration of a test meal and continuous aspiration of duodenal contents. Pancreatic lipase outputs in CP patients were very low (0.7 ± 0.2 mg) versus HVs (116.7 ± 68.1 mg; P < 0.005), thus confirming the severity of EPI. Duodenal BA outputs were reduced in CP patients (1.00 ± 0.89 mmol; 0.47 ± 0.42 g) versus HVs (5.52 ± 4.53 mmol; 2.62 ± 2.14 g; P < 0.15). Primary to secondary BA ratio was considerably higher in CP patients (38.09 ± 48.1) than HVs (4.15 ± 2.37; P < 0.15), indicating an impaired transformation of BAs by gut microbiota. BA concentrations were found below the critical micellar concentration in CP patients, while a high BA concentration peak corresponding to gallbladder emptying was evidenced in HVs. Conversely, BA plasma concentration was increased in CP patients versus HVs suggesting a cholangiohepatic shunt of BA secretion. Alterations of BA circulation and levels may result from the main biliary duct stenosis observed in these CP patients and may aggravate the consequences of EPI on lipid malabsorption.
Copyright © 2018 Humbert et al.

Entities:  

Keywords:  cholangiohepatic shunt; exocrine pancreatic insufficiency; lipidomics

Mesh:

Substances:

Year:  2018        PMID: 30206181      PMCID: PMC6210915          DOI: 10.1194/jlr.M084830

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  49 in total

1.  THE FUNCTION OF BILE SALTS IN FAT ABSORPTION. THE SOLVENT PROPERTIES OF DILUTE MICELLAR SOLUTIONS OF CONJUGATED BILE SALTS.

Authors:  A F HOFMANN
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

2.  Tributyrine as a substrate for determination of lipase activity of pancreatic juice and small intestinal content.

Authors:  C Erlanson; B Borgström
Journal:  Scand J Gastroenterol       Date:  1970       Impact factor: 2.423

3.  [Bile salts and lipids in aqueous intraluminal phase during the digestion of a standard meal in normal man (author's transl)].

Authors:  M Rautureau; A Bisalli; J C Rambaud
Journal:  Gastroenterol Clin Biol       Date:  1981-04

Review 4.  Bile acid solubility and precipitation in vitro and in vivo: the role of conjugation, pH, and Ca2+ ions.

Authors:  A F Hofmann; K J Mysels
Journal:  J Lipid Res       Date:  1992-05       Impact factor: 5.922

5.  Quantitative study of digestive enzyme secretion and gastrointestinal lipolysis in chronic pancreatitis.

Authors:  Frédéric Carrière; Philippe Grandval; Christophe Renou; Aurélie Palomba; Florence Priéri; Jacqueline Giallo; Friederike Henniges; Suntje Sander-Struckmeier; René Laugier
Journal:  Clin Gastroenterol Hepatol       Date:  2005-01       Impact factor: 11.382

Review 6.  Bile acids: chemistry, physiology, and pathophysiology.

Authors:  Maria J Monte; Jose J G Marin; Alvaro Antelo; Jose Vazquez-Tato
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

7.  Postprandial evolution in composition and characteristics of human duodenal fluids in different nutritional states.

Authors:  S Clarysse; J Tack; F Lammert; G Duchateau; C Reppas; P Augustijns
Journal:  J Pharm Sci       Date:  2009-03       Impact factor: 3.534

Review 8.  Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics.

Authors:  A F Hofmann; L R Hagey
Journal:  Cell Mol Life Sci       Date:  2008-08       Impact factor: 9.261

9.  Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis.

Authors:  Jeffery L Smith; Peter J Lewindon; Anita C Hoskins; Tamara N Pereira; Kenneth D R Setchell; Nancy C O'Connell; Ross W Shepherd; Grant A Ramm
Journal:  Hepatology       Date:  2004-06       Impact factor: 17.425

10.  Bile Acid Metabolome after an Oral Lipid Tolerance Test by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).

Authors:  Andreas Schmid; Hannah Neumann; Thomas Karrasch; Gerhard Liebisch; Andreas Schäffler
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

View more
  3 in total

1.  Clinical validation of an evidence-based method to adjust Pancreatic Enzyme Replacement Therapy through a prospective interventional study in paediatric patients with Cystic Fibrosis.

Authors:  Joaquim Calvo-Lerma; Jessie Hulst; Mieke Boon; Carla Colombo; Etna Masip; Mar Ruperto; Victoria Fornés-Ferrer; Els van der Wiel; Ine Claes; Maria Garriga; Maria Roca; Paula Crespo-Escobar; Anna Bulfamante; Sandra Woodcock; Sandra Martínez-Barona; Ana Andrés; Kris de Boeck; Carmen Ribes-Koninckx
Journal:  PLoS One       Date:  2019-03-12       Impact factor: 3.240

2.  A first approach for an evidence-based in vitro digestion method to adjust pancreatic enzyme replacement therapy in cystic fibrosis.

Authors:  Joaquim Calvo-Lerma; Victoria Fornés-Ferrer; Irene Peinado; Ana Heredia; Carmen Ribes-Koninckx; Ana Andrés
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

3.  Impact of Processing and Intestinal Conditions on in Vitro Digestion of Chia (Salvia hispanica) Seeds and Derivatives.

Authors:  Joaquim Calvo-Lerma; Carolina Paz-Yépez; Andrea Asensio-Grau; Ana Heredia; Ana Andrés
Journal:  Foods       Date:  2020-03-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.